Announcements
- IMMUPHARMA AT BIO-EQUITY 2024 12-14 May
- Grant of Share Options
- New intellectual property strategy initiated
- Incanthera provides Comm'l Update/Revenue F'casts
- Grant of Share Options
- IMMUPHARMA AT BIO-EUROPE SPRING 2024
- Financial, Business and Portfolio Develop't Update
- Holding(s) in Company
- Simbec-Orion appointed as CRO
- Incanthera - Comm'l Skincare Deal/£1M Fundraise
More ▼
Key statistics
As of last trade ImmuPharma PLC (25I:MUN) traded at 0.028, -18.13% below its 52-week high of 0.0342, set on Jun 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.028 |
---|---|
High | 0.028 |
Low | 0.028 |
Bid | 0.0135 |
Offer | 0.0345 |
Previous close | 0.028 |
Average volume | 0.00 |
---|---|
Shares outstanding | 416.44m |
Free float | 237.37m |
P/E (TTM) | -- |
Market cap | 8.47m GBP |
EPS (TTM) | -0.0092 GBP |
Data delayed at least 15 minutes, as of May 02 2024 07:10 BST.
More ▼